Literature DB >> 6705300

Adverse reactions to protamine sulfate following cardiac surgery.

C L Holland, A K Singh, P R McMaster, W Fang.   

Abstract

We report four patients who developed severe adverse reactions to protamine sulfate following cardiac surgery. Two types of reactions were seen. First, an immediate anaphylaxis which is a complement-dependent IgG antibody-mediated reaction. In the literature, 80% of patients who had similar reactions have had previous exposure to protamine. All patients adequately tested had positive skin tests and there is 6% mortality. The second reaction to protamine during cardiac surgery is characterized by delayed onset and profound vascular damage presenting as noncardiogenic pulmonary edema or total vascular collapse with prolonged hypotension and anasarca. These patients have negative skin tests and in our studies, no evidence of antibody mediated reaction, suggesting some other mechanisms may play a part. The mortality is high (30% of patients reported) and survivors have significant morbidity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705300     DOI: 10.1002/clc.4960070305

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  4 in total

1.  The beneficial effects of aminophylline administration on heparin reversal with protamine.

Authors:  S F Katircioglu; D S Küçükaksu; M Bozdayi; K Dalva; B Mavitaş; Y Zorlutuna; O Taşdemir; K Bayazit
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

2.  Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.

Authors:  Patrick O Wagers; Kristin M Tiemann; Kerri L Shelton; William G Kofron; Matthew J Panzner; Karen L Wooley; Wiley J Youngs; David A Hunstad
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

3.  An anaphylactic reaction to protamine sulfate.

Authors:  J A Roelofse; P van der Bijl
Journal:  Anesth Prog       Date:  1991 May-Jun

4.  The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin.

Authors:  Emilia Sokolowska; Bartlomiej Kalaska; Kamil Kaminski; Alicja Lewandowska; Agnieszka Blazejczyk; Joanna Wietrzyk; Irena Kasacka; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.